Sequential treatment of metastatic renal cell carcinoma patients after first-line vascular endothelial growth factor targeted therapy in a real-world setting: epidemiologic, noninterventional, retrospective–prospective cohort multicentre study

PURPOSE: The purpose of our study was to determine whether data on the clinical effectiveness of second-line therapy collected in a real-world setting provide additional valuable information on the optimal sequence of metastatic renal cell carcinoma (mRCC) treatment. METHODS: Patients diagnosed with...

Descripción completa

Detalles Bibliográficos
Autores principales: Cesas, Alvydas, Urbonas, Vincas, Tulyte, Skaiste, Janciauskiene, Rasa, Liutkauskiene, Sigita, Grabauskyte, Ingrida, Gaidamavicius, Ignas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374746/
https://www.ncbi.nlm.nih.gov/pubmed/36847839
http://dx.doi.org/10.1007/s00432-023-04645-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374746/
https://www.ncbi.nlm.nih.gov/pubmed/36847839
http://dx.doi.org/10.1007/s00432-023-04645-x

Ejemplares similares